Article Text

Download PDFPDF
Visual impairment due to retinopathy of prematurity (ROP) in New Zealand: a 22-year review
  1. Zachary Tan1,
  2. CheeFoong Chong2,3,
  3. Brian Darlow4,
  4. Shuan Dai2,3
  1. 1School of Medicine, The University of Queensland, Brisbane, Queensland, Australia
  2. 2Department of Ophthalmology, University of Auckland, Auckland, New Zealand
  3. 3Department of Ophthalmology, Greenlane Clinical Centre, Auckland, New Zealand
  4. 4Department of Paediatrics, University of Otago, Christchurch, New Zealand
  1. Correspondence to Dr Shuan Dai, Department of Ophthalmology, Greenlane Clinical Centre, Private Bag 92-189, Auckland 1024, New Zealand; shuandai{at}


Aim To evaluate retinopathy of prematurity (ROP)-related visual impairment in New Zealand children.

Methods 22-year retrospective review of medical records of children with moderate to severe visual impairment registered with the Blind and Low Vision Education Network New Zealand. The cohort was divided into two periods (1991–2004; 2005–2012) for analysis.

Results 232 children with ROP were treated in the study period (109 in period 1, 123 in period 2). 36 children, 63.9% of whom were of male sex, were identified with subsequent significant visual impairment (27 in period 1, 9 in period 2). The incidence of new cases of visual impairment from ROP declined from 271.6 infants/100 000 live very preterm births per annum (period 1) to 146.1 per annum (period 2). Mean gestational age and mean birth weight were comparable between the two study periods. 75% of children with visual impairment from ROP received treatment for their condition (period 1, 74.1%; period 2, 77.8%) and modalities used changed significantly over time. The modal visual outcome overall was Snellen visual acuity <6/18–6/60 (55.6%) (period 1, 51.9%; period 2, 66.7%). The proportion of children with no light perception bilaterally decreased over time (period 1, 3.7%; period 2, 0%).

Conclusions There has been a reduction in the incidence of infants with significant visual impairment from ROP over time in New Zealand, likely due to progress in clinical management of ROP. Our study suggests the current ROP screening criteria of <31 weeks' gestation or <1250 g are of sufficient breadth.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • At a glance
    Keith Barton James Chodosh Jost Jonas